Legal Representation
Attorney
Rachel Pilloff
USPTO Deadlines
Next Deadline
1953 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250506)
Due Date
May 06, 2031
Grace Period Ends
November 06, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 6, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 6, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 6, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 6, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 11, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 11, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 11, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 11, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 5, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 5, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 16, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 16, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 16, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 16, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 16, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 16, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 16, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 16, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 16, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 16, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 3, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 3, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 3, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 3, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 3, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 3, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 24, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 24, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 24, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 24, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 24, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 24, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 19, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 19, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 9, 2024 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Sep 9, 2024 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Sep 9, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 9, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 12, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Apr 12, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Apr 10, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Apr 10, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Diagnostic preparations for scientific purposes; Diagnostic preparations for scientific or research use; Diagnostic preparations other than for medical or veterinary purposes; Clinical diagnostics preparations, other than for medical or veterinary use; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic reagents, other than for medical or veterinary use for sale in kit form; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostics preparations for immunosuppression identification for scientific or research purposes for sale in kit form; Diagnostics preparations for immunosuppression identification other than for medical or veterinary purposes for sale in kit form; Diagnostic test kits for the detection of sepsis for scientific or research purposes
Class 005
Diagnostic preparations and agent materials for medical purposes; Medical diagnostic test strips for blood analysis; Diagnostic testing materials for medical use; In vitro diagnostic preparations for medical use; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Reagents and media for medical and veterinary diagnostic purposes; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sepsis; Diagnostic preparations for the detection of sepsis for medical use; Diagnostic preparations for immunosuppression identification for medical use; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, for immunosuppression identification
Classification
International Classes
001
005